Thirty-eight hallmark gene sets showed the difference in the normal bladder mucosae, bladder mucosae surrounding cancer, TCBC and recurrent tumour samples, including the UPR pathway, E2F targets, G2M checkpoint, P53 pathway, Wnt/beta-catenin signalling etc (SupplementaryFigure S1). This evidence concerns the gene TP53 and cancer.